InterAct Receives Additional Funding to Pilot Cognitive Enhancement Therapy


InterAct has received the final component of project funding from the Harold and Grace Upjohn Foundation to match funds already received from Irving S. Gilmore Foundation, Kalamazoo Community Foundation, Dorothy U. Dalton Foundation, and Kalamazoo Community Mental Health and Substance Abuse Services (KCMHSAS) for development of develop Cognitive Enhancement Therapy (CET) to help people with schizophrenia and other mental illnesses in our community to improve their processing speed, cognition, and social cognition.  Cognition is the major source of disability for people that are recovering from mental illness.  CET is an evidence-based treatment model that targets cognitive deficits that limit recovery.  While medications are needed for most people in recovery, they are not effective in improving cognition.  CET uses a combination of computer exercises, social cognition groups, and individual therapy to achieve long-lasting positive results such as improved memory, attention span, and vocational effectiveness.

InterAct began a 14 month pilot in October 2012 to become certified in provision of CET for residents of the Kalamazoo area.  Wendy Maayan from the Center for Cognition and Recovery (CCR) in Cleveland is our designated trainer for the year through weekly videoconferencing and monthly on-site visits to Kalamazoo.  Randy Wolbert is leading the InterAct clinical team consisting of Dawn Bouaouad, Alexandra Chambers, Chandelle Johnson, Joanna Pratt, and Deb Wickman.  They’re piloting CET with a group of 20-24 individuals.   We will be tracking outcomes for participants to measure the effectiveness of this new treatment.  For more information on CET see: